Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study. Blood Advances 2024 December 11

https://read.qxmd.com/read/39661985/safety-and-efficacy-of-glofitamab-for-relapsed-refractory-large-b-cell-lymphoma-in-a-multinational-real-world-study?uac=148436CN&ecd=wnl_readmost_241227&sso=true&redirected=slug